What Tianlong does

Tianlong Technology (苏州天隆生物科技有限公司) is a Chinese molecular diagnostics company founded in 1997 and headquartered between Xi'an and Suzhou. The company develops, manufactures, and sells in vitro diagnostic (IVD) instruments and reagents built on three core technology platforms: PCR technology, gene chip technology, and sequencing technology. Its product portfolio spans nucleic acid extraction instruments, real-time fluorescent quantitative PCR systems, gene amplification thermal cyclers, point-of-care testing (POCT) devices, handheld ATP fluorescence detectors, and more than 300 reagent kit varieties covering infectious diseases, genetic diseases, oncology, pharmacogenomics, and life science research.

The company's flagship engineering work centers on magnetic bead nucleic acid extraction chemistry combined with fluorescent PCR detection, packaged into integrated pipelines such as the PANA HM5000 sample-in/results-out workstation. Tianlong holds 100+ patents, approximately 20+ NMPA Class III medical device registrations, nearly 80 overseas registrations, and led the YY/T1717-2020 national standard for magnetic bead nucleic acid extraction kits — the first of its kind in China's IVD industry. The company received the 2020 National Science and Technology Progress Award (Second Prize) and the 25th China Patent Excellence Award in 2024.

Commercially, Tianlong operates a sales-led go-to-market with direct sales to Class III hospitals, CDC centers, and third-party medical testing institutions across 30+ Chinese provinces, supplemented by government tender and institutional procurement. Revenue streams comprise hardware sales (instruments), reagent sales (treated as one-time licenses in the source), and third-party medical laboratory services. Overseas expansion uses a mix of direct export and channel partner models, including a September 2025 exclusive global distribution partnership with Yirui Bio for the Biolum ATP handheld product line. The company is strategically backed by Shanghai Kehua Bio-engineering (Shenzhen: 002022), which holds a controlling parent position following its 2018 strategic investment, and previously received capital from SK Group in 2012. Products are deployed in over 100 countries and regions globally.

Name

Tianlong

Legal name

苏州天隆生物科技有限公司

Website

https://medtl.cn

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Tianlong is a Chinese molecular diagnostics company that develops and manufactures nucleic acid extraction instruments, real-time PCR systems, and 300+ reagent kits for hospitals, CDC centers, and third-party testing institutions domestically and across 100+ export markets.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics / In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular & Genomic LIMS (NGS/Bioinformatics Lab Ops) (HLACAMAC)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Reference & Esoteric Testing Laboratories (HLAFAMAJ)

Keywords

• Molecular diagnostics
• In vitro diagnostics
• Nucleic acid extraction
• PCR instruments
• Diagnostic reagents

Headquarters

HQ city

Suzhou

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. 分子诊断仪器销售: Sale of nucleic acid extraction instruments, real-time fluorescent quantitative PCR instruments, automated workstations, and other molecular diagnostic equipment.
2. 体外诊断试剂销售: Sale of supporting reagents including nucleic acid extraction reagents, fluorescent quantitative PCR detection reagents covering infectious diseases, genetic diseases, tumors, and precision medicine applications. Over 100 reagent varieties.
3. 第三方医学检验服务: Third-party medical laboratory testing services.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Tianlong is a privately held Chinese molecular diagnostics and in vitro diagnostic (IVD) company that researches, manufactures, and sells nucleic acid extraction instruments, real-time fluorescent quantitative PCR instruments, gene amplification thermal cyclers, automated sample-to-result pipelines (e.g., PANA HM5000), handheld ATP fluorescence detectors (Biolum), POCT devices, and over 300 matching diagnostic reagent kits covering infectious diseases, genetic diseases, tumors, pharmacogenomics, food safety, and life sciences. The company also provides third-party medical laboratory testing services and supplies reagents to hospitals, CDC centers, third-party testing institutions, and life science research bodies across 30+ Chinese provinces and 100+ countries.

Product overview

Tianlong is a molecular diagnostics company offering an integrated portfolio of nucleic acid extraction instruments, real-time fluorescent quantitative PCR systems, gene amplification equipment, and POCT devices, along with matching reagent kits. The product ecosystem includes the PANA HM5000 automated nucleic acid purification and amplification detection system (sample-in results-out pipeline), Genesy 96T gene amplification thermal cycler, Biolum handheld ATP fluorescence detector, and hundreds of reagent kits spanning clinical diagnostics (infectious diseases, genetic diseases, pharmacogenomics, tumor markers) and life science applications (animal disease, food safety, plant detection). The platform combines magnetic bead nucleic acid extraction technology with fluorescent PCR detection for applications in medical testing, disease control, food safety, and scientific research.

Differentiator

Problem solved

Functional benefit

Brands

• 天隆智造 (Tianlong Zhizao): Brand for Tianlong's self-developed molecular diagnostics instruments and reagents
• Biolum

Products and services

• Nucleic Acid Extraction Equipment (核酸提取设备) Automated nucleic acid extraction instruments using magnetic bead technology, handling various sample types (whole blood, serum, swabs, feces, tissues) for clinical and life science molecular diagnostics workflows.
• Real-time Fluorescent Quantitative PCR Equipment (实时荧光定量PCR设备) Real-time fluorescent quantitative PCR instruments designed for high-sensitivity and high-specificity pathogen identification and genetic analysis in clinical and research laboratories.
• Gene Amplification PCR Equipment (基因扩增PCR设备) Gene amplification thermal cyclers for PCR-based nucleic acid testing, supporting standard PCR workflows in clinical and research settings.
• Genesy 96T Gene Amplification Thermal Cycler (Genesy 96T基因扩增热循环仪) Next-generation gene amplification thermal cycler with 7-inch TFT touchscreen, Linux OS, 5.5°C/s heating/cooling rate, and gradient temperature control, supporting standard PCR, RT-PCR, nested PCR, touchdown PCR, long fragment PCR, and gradient PCR for medical, food, environmental, life science research, and forensic identification applications.
• PANA HM5000 Automated Nucleic Acid Purification and Amplification Detection System (PANA HM5000全自动核酸纯化及扩增检测分析系统) Automated, high-throughput, high-compatibility, high-safety molecular diagnostic pipeline based on rotation mixing + magnetic bead nucleic acid extraction and fluorescent PCR technology, achieving 'sample in-results out' processing at 96 samples per run while supporting uninterrupted emergency testing. Integrates with hospital LIS systems for infectious disease testing, genetic disease testing, personalized medication, tumor screening, prenatal testing, and livestock disease prevention.
• Biolum Handheld ATP Fluorescence Detector (Biolum手持式ATP荧光检测仪) Handheld ATP fluorescence detector for surface cleanliness and water sample detection, completing detection in 10 seconds with high sensitivity. Used in food processing, catering, medical/health, antibacterial industries, and environmental monitoring. Has supported G20 Summit, Davos Forum, and National Games food safety assurance.
• POCT Devices (POCT设备) Point-of-care testing devices for rapid molecular diagnostics at decentralized locations such as grassroots medical institutions and field testing sites.
• Clinical Reagent Series (临床试剂系列) Clinical diagnostic reagent kits covering infectious diseases, genetic diseases, tumors, and precision medicine applications, designed to be used with Tianlong's nucleic acid extraction and PCR instruments.
• Life Science Reagent Series (生命科学试剂系列) Life science research reagents for molecular biology applications such as genetic testing research, forensic identification, animal and plant-derived component detection.
• ATP Quickswab Test Swabs (ATP检测拭子) ATP Quickswab detection swabs compatible with the Biolum handheld ATP fluorescence detector for surface cleanliness and water sample testing. Models include A010 (Liquswab Total), A011 (Liquswab Free), A016, A017, A036, A037, A038. Used in food processing, catering, medical/health, antibacterial industries, and environmental monitoring.
• Magnetic Bead Nucleic Acid Extraction Reagents (磁珠法核酸提取试剂) Magnetic bead method nucleic acid extraction reagents covering nearly 100 reagent types across 10 categories, supporting sample types including whole blood, serum, swabs, feces, and tissues. Available in pre-filled (20T/40T/64T) and non-pre-filled (20T/50T/200T) specifications. Completes 96 samples' nucleic acid purification in approximately 10 minutes.
• Fluorescent Quantitative PCR Detection Reagents - Clinical (荧光定量PCR检测试剂) Real-time fluorescent quantitative PCR detection reagents with high sensitivity, strong specificity, and simple operation. Categories include Respiratory Series (influenza, avian influenza, coronaviruses, MERS), Gastrointestinal Series, Fever with Rash Series, Diarrhea Series, Encephalitis/Meningitis Series, Fever with Hemorrhage Series, Blood Screening, Genetic Disease Series (HLA-B27, SMA/SMN1), STD Series (CT, NG, UU, HPV), Hepatitis Series (HBV, HCV), Tumor Series (EBV, BRAF, KRAS), and Pharmacogenomics Series (CYP2C19, CYP2D6, HLA-B*5801, ApoE, SLCO1B1, VKORC1, MTHFR, ALDH2).
• Fluorescent Quantitative PCR Detection Reagents - Life Science Series (荧光定量PCR检测试剂·生命科学系列) Life science fluorescent quantitative PCR reagents covering respiratory infections, avian influenza viruses, coronaviruses, diarrhea pathogens, encephalitis pathogens, animal diseases, animal-derived component detection, and plant-derived component detection.
• 9-Plex Tick-borne Disease Nucleic Acid Detection Reagent (9重蜱传病核酸检测试剂) Real-time fluorescent quantitative PCR detection reagent for precise detection of 9 tick-borne diseases, part of the infectious disease detection product line.
• 13-Plex Encephalitis/Meningitis Syndrome Pathogen Nucleic Acid Detection Reagent (13重脑炎脑膜炎症候群核酸检测试剂) Real-time fluorescent quantitative PCR detection reagent for detection of 13 types of encephalitis/meningitis syndrome pathogens.
• Human CYP2C9 and VKORC1 Gene Polymorphism Detection Kit (人类CYP2C9及VKORC1基因多态性检测试剂盒) Fluorescent PCR method human CYP2C9 and VKORC1 gene polymorphism detection kit for guiding individualized use of warfarin, celecoxib and other drugs.
• Human CYP2C19 Gene Polymorphism Detection Kit (人类CYP2C19基因多态性检测试剂盒) Fluorescent PCR method human CYP2C19 gene polymorphism detection kit for guiding individualized use of clopidogrel, omeprazole, citalopram, voriconazole and other drugs.
• Human CYP2D6 Gene Polymorphism Detection Kit (人类CYP2D6基因多态性检测试剂盒) Fluorescent PCR method human CYP2D6 gene polymorphism detection kit for guiding individualized use of psychiatric medications and tamoxifen.
• Gentier X3 Series Real-time Fluorescent Quantitative PCR Instrument (Gentier X3系列实时荧光定量PCR仪) Real-time fluorescent quantitative PCR instrument with 3-module design and 32-sample throughput, providing flexible detection capacity for medium-throughput clinical and research laboratories.
• Third-party Medical Laboratory Testing Services (第三方医学检验服务) Third-party medical laboratory testing services offered by Tianlong to complement its IVD product portfolio, providing diagnostic testing capacity to hospitals, clinics, and other healthcare providers.

Quantifiable outcome

• National Science and Technology Progress Award Second Prize (2020)
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• 深圳市易瑞生物技术股份有限公司 (Yirui Bio)coreChannel Partner/ Reseller/ Distributor · 4 September 2025Strategic cooperation for overseas sales of Tianlong's Biolum handheld ATP fluorescence detector. Yirui Bio granted exclusive global distribution rights (excluding China and a few countries) for Biolum ATP products. Formed a 'dual-brand' cooperation model to jointly expand overseas food safety testing markets and build global food safety protection network.
• 意大利 Technogenetics S.P.A. (TGS)coreStrategic or Co-development PartnerJoint exhibition partner at MEDICA 2024 and Medlab Dubai 2025. Part of group collaboration with parent company KeHua Bio for international market expansion.
• 西安交通大学coreStrategic or Co-development PartnerIndustry-academia-research cooperation with Xi'an Jiaotong University. Tianlong founder Peng Niancai is a professor at the university. Joint development of key technologies and talent cultivation.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Hologic: Global molecular diagnostics leader with Panther automated system for high-volume PCR testing. Competes in the integrated automated molecular diagnostic workflow category where Tianlong's PANA HM5000 operates.
• Cepheid (Danaher): Global leader in molecular diagnostics with GeneXpert rapid PCR systems deployed in hospitals worldwide. Represents the integrated sample-to-result automation standard Tianlong's PANA HM5000 competes against in international markets.
• Qiagen: Global molecular sample preparation and testing company with nucleic acid extraction reagents and PCR platforms. Directly comparable to Tianlong's magnetic bead extraction reagent business and instrument portfolio.
• Shanghai Kehua Bio-engineering: Tianlong's strategic parent company and broader Chinese IVD incumbent listed on Shenzhen Stock Exchange (002022). Operates overlapping molecular diagnostics business with larger scale and broader product portfolio spanning immunoassay, clinical chemistry, and molecular diagnostics.
• Roche Diagnostics: Global IVD incumbent offering cobas PCR systems and broad infectious disease test menu. Competes with Tianlong in high-end molecular diagnostics, particularly in international hospital procurement and reference lab markets.

Direct peers

• Sansure Biotech: Leading Chinese IVD company specializing in molecular diagnostic reagents and instruments (PCR, nucleic acid extraction) with global reach comparable to Tianlong. Most direct competitor in Chinese molecular diagnostics with overlapping hospital and CDC channels.
• Autobio Diagnostics: Chinese IVD company providing molecular diagnostic instruments and reagents with comparable hospital distribution model. Competes with Tianlong in clinical microbiology and infectious disease testing segments.
• BGI Genomics: China's largest genomics and molecular diagnostics company offering PCR reagents, sequencers, and infectious disease testing kits. Direct competitor across Tianlong's instrument and reagent categories with broader sequencing-based portfolio.
• DaAn Gene (Sun Yat-sen University DaAn Gene): Major Chinese molecular diagnostics player with strong hospital channel presence for PCR-based infectious disease and genetic testing reagents. Overlapping product categories and target customer base with Tianlong.

Regional players

• Mylab Discovery Solutions: Indian molecular diagnostics company focused on PCR-based infectious disease and genetic testing kits. Comparable product category to Tianlong but serving primarily South Asian and emerging markets rather than Chinese domestic.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tianlong